Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria

BACKGROUND: Hydroxyurea (HU) is an evidence-based therapy that is currently the most effective drug for sickle cell disease (SCD). HU is widely used in high-income countries with consequent reduction of morbidity and mortality. In Nigeria, HU is prescribed by physicians while nurses are mainly invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Isa, Hezekiah Alkali, Nnebe-Agumadu, Uche, Nwegbu, Maxwell M., Okocha, Emmanuel C., Chianumba, Reuben I., Brown, Biobele J., Asala, Samuel A., Peprah, Emmanuel, Nnodu, Obiageli E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682971/
https://www.ncbi.nlm.nih.gov/pubmed/36355850
http://dx.doi.org/10.1371/journal.pone.0276639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682971/
https://www.ncbi.nlm.nih.gov/pubmed/36355850
http://dx.doi.org/10.1371/journal.pone.0276639

Ejemplares similares